Bioventus and MTF Biologics collaborate to develop placental tissue product for knee osteoarthritis

[Ketua Dobbs]

Bioventus and MTF Biologics collaborate to develop placental tissue product for knee osteoarthritis

Bioventus, a global leader in orthobiologic solutions, has entered into a development collaboration agreement with MTF Biologics, the world’s largest tissue bank, to co-develop a next generation placental tissue product for the treatment of painful musculoskeletal conditions, with an initial focus on knee osteoarthritis.
Source: Bioventus and MTF Biologics collaborate to develop placental tissue product for knee osteoarthritis